Helping the World to See Clearly

Every 5 seconds, someone in the world will lose the ability to see. According to the World Health Organization, there are currently 40 million people around the globe who are blind, with more than half in China, India and sub-Saharan Africa.

An aging population, and the increasing rate of chronic health conditions due to excessive calorie intake and increasingly sedentary lifestyles, are boosting the rate of vision loss at an exponential rate. People over 60 are in the highest risk category for age related eye disease. They are also the fastest growing population segment with the United Nations projecting over 60’s to number 1.4 billion by 2030.

The need for vision protecting and eye-care technologies has never been greater, a challenge we have met head-on with our game changing ophthalmic technologies.

Since 1985, Ellex has been at the forefront of ophthalmic laser research and development, combining the engineering might of the defence industry, with the medical insight of major universities to create ophthalmic remedies once never thought possible.

As pioneers in the industry, we continue to discover new and innovative ways to harness the healing power of laser technology, and in turn, help to transform the lives of people across the globe. Today, more than 30,000 Ellex ophthalmic laser and ultrasound systems are in use worldwide. The latest addition to the Ellex product family is ABiC; a restorative MIGS procedure, which uses our proprietary iTrack(TM) microcatheter technology to restore the eye’s natural outflow pathways in the treatment of glaucoma.

Ophthalmic Research: Pushing the Envelope

Ellex maintains a strong emphasis on intellectual property and research into new and better treatments for ophthalmic disease. We are constantly pushing the envelope in terms of what ophthalmic technology can accomplish. Among our current research efforts is 2RT™ (also known as Retinal Rejuvenation Therapy), a breakthrough laser procedure currently undergoing clinical trial for early Age-Related Macular Degeneration (AMD). Unlike currently marketed treatments for AMD, which only treat the late stages of the disease, 2RT™ offers the potential to intervene much earlier before significant vision loss occurs.

Our Manufacturing Expertise is Our Greatest Asset

Our state-of-the-art manufacturing facility employs the latest production techniques and a team of highly trained technicians specialized in opto-electronics. Recognized as the short-pulsed laser experts, some of the industry’s largest companies including Coherent (now Lumenis) have entrusted us to manufacture their ophthalmic lasers. Over the years Ellex has evolved from a manufacturing company of primarily original equipment manufacture (OEM) products, to direct marketing of our own branded products and services through subsidiaries in the United States, Japan, Germany, France and Australia, and a network of distribution partners in more than 100 countries.

A Commitment to Customer Care

The Ellex name has long been synonymous with excellence in technology, in quality, and in customer care. We maintain the highest quality standards through product development and manufacturing, and strive to provide unmatched levels of clinical expertise and support to our customers. All of these efforts have combined to produce one of the highest levels of customer satisfaction in the medical industry.